Strategic Investment WindRose Health Investors invested in Verified Clinical Trials, signaling strong growth potential and a favorable funding trajectory that can enable expanded data capabilities and enterprise sales to sponsors, CROs, and sites.

Insurance Synergy Chubb Ltd integration combines clinical trial insurance with VCT’s subject registry technology, creating a compelling cross-sell opportunity to sponsors and CROs seeking end-to-end risk management and enrollment integrity.

Double EnrollmentMitigation Partnerships with Velocity Clinical Research emphasize addressing double enrollment and data quality, offering a ready-made use case to win multi-site agreements and expand into velocity’s 80+ global sites.

Global Adoption VCT’s global reach across multiple therapeutic indications and all trial phases positions it to upsell to international sponsors and CROs seeking scalable, standardized participant safety and data integrity solutions.

Market Readiness With a revenue range of one to ten million and a lean team, VCT can target mid-market sponsors, regional CROs, and trial sites that need cost-effective, rapid-deployment registry and verification services to boost safety and compliance.